GENNEX LAB. Fact Sheet, GENNEX LAB. Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENNEX LAB. Fact Sheet    (PPHM)


QUICK REQUEST: Grab Your Free Spot at Richa's Summit Now


Here is the latest financial fact sheet of GENNEX LAB.. For more details, see the GENNEX LAB. quarterly results and GENNEX LAB. share price and chart. For a sector overview, read our pharmaceuticals sector report.

GENNEX LAB. Price History

Price Rs 7.2
Mkt Cap Rs m 906
Vol '000 634.2
P/E X 17.3
P/CF X 18.4
EPS (TTM) Rs 0.4
% ch % 1.3
No. of shares m 126.50
% ch week % 2.1
% ch 1-mth % 3.8
% ch 12-mth % 63.5
52 week H/L Rs 12.9/3.6
(As on Nov 26, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

GENNEX LAB. Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
GENNEX LAB. EQUITY SHARE DATA
High Rs98646 
Low Rs43212 
Sales per share (Unadj.) Rs3.23.24.14.14.4 
Earnings per share (Unadj.) Rs0.20.10.20.10.3 
Diluted earnings per shareRs0.20.10.20.10.3 
Cash flow per share (Unadj.) Rs0.30.10.30.20.4 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs2.42.52.72.83.1 
Adj. book value per shareRs2.42.52.72.83.1 
Shares outstanding (eoy) m126.50126.50126.50126.50126.50 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x2.11.81.00.70.9 
Avg P/E ratio x31.184.722.619.512.3 
P/CF ratio (eoy) x23.840.315.712.610.1 
Price / Book Value ratio x2.72.21.51.01.3 
Dividend payout %00000 
Avg Mkt Cap Rs m842708503361498 
No. of employees `000NANANANANA 
Total wages/salary Rs m5055616872 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
GENNEX LAB. INCOME DATA
Net Sales Rs m403403516513556 
Other income Rs m198105 
Total revenues Rs m404412524522562 
Gross profit Rs m4522403462 
Depreciation Rs m8910109 
Interest Rs m77887 
Profit before tax Rs m3115302551 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m468710 
Profit after tax Rs m278221940 
Gross profit margin %11.25.57.86.511.1 
Effective tax rate %12.842.526.627.220.2 
Net profit margin %6.72.14.33.67.3 
GENNEX LAB. BALANCE SHEET DATA
Current assets Rs m262277290350377 
Current liabilities Rs m171177173209190 
Net working cap to sales %22.624.822.727.533.5 
Current ratio x1.51.61.71.72.0 
Inventory Days Days6565505047 
Debtors Days Days93957344,699,36058,680,596 
Net fixed assets Rs m230228227220212 
Share capital Rs m127127127127127 
"Free" reserves Rs m183191212230271 
Net worth Rs m309318338357397 
Long term debt Rs m24000 
Total assets Rs m492505517569589 
Interest coverage x5.43.04.84.47.8 
Debt to equity ratio x00000 
Sales to assets ratio x0.80.81.00.90.9 
Return on assets %6.93.15.84.68.1 
Return on equity %8.72.66.65.210.2 
Return on capital %12.26.811.39.314.6 
Exports to sales %32.629.245.542.941.2 
Imports to sales %3.75.114.214.54.4 
Exports (fob) Rs m132118235220229 
Imports (cif) Rs m1520737424 
Fx inflow Rs m132118235220229 
Fx outflow Rs m1728817929 
Net fx Rs m11590153141201 
GENNEX LAB. CASH FLOW
From Operations Rs m -1 32 19 -17 -14 
From Investments Rs m -10 -7 -10 -2 0 
From Financial Activity Rs m 9 -21 12 -3 16 
Net Cashflow Rs m -2 4 21 -22 2 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 22.1%
Institution 0.0%
Non-Institution 78.0%
Total 100.0%
Free Float 78.0%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Sy . No . 133, Bollaram, Jinnaram Mandal Medak Dist, Bollaram - 502325
E-MAIL investorrelations@gennexlab.com WEB www.gennexlab.com
TEL 08458-279516 /279406 FAX 08458-279516
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT R&D Infotech Pvt Ltd, 15 C Ground Floor, Naresh Mitra Sarani (Beltala Road) Road
YEAR OF INC: 1990 BSE CODE: 531739 FV (Rs): 1 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   CHEMO PHARMA  BAFNA PHARMA  TRANS ASIA CORP  EVEREST ORGANICS  AUROBINDO PHARMA  

Compare GENNEX LAB. With:   CHEMO PHARMA  BAFNA PHARMA  TRANS ASIA CORP  EVEREST ORGANICS  AUROBINDO PHARMA  




Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Views on news

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime (Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK GENNEX LAB.

  • Track your investment in GENNEX LAB. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GENNEX LAB.

GENNEX LAB. - TEVA PHARMA COMPARISON

COMPARE GENNEX LAB. WITH

MARKET STATS